Cover Image

<i>CYP3A53</i> and <i>CYP3A422</i> Cluster Polymorphism Effects on LCP-Tac Tacrolimus Exposure: Population Pharmacokinetic Approach

The aim of the study is to develop a population pharmacokinetic (PopPK) model and to investigate the influence of CYP3A5/CYP3A4 and ABCB1 single nucleotide polymorphisms (SNPs) on the Tacrolimus PK parameters after LCP-Tac formulation in stable adult renal transplant patients. The model was develope...

Full description

Saved in:

Bibliographic Details
Main Authors:	Zeyar Mohammed Ali (Author), Marinda Meertens (Author), Beatriz Fernández (Author), Pere Fontova (Author), Anna Vidal-Alabró (Author), Raul Rigo-Bonnin (Author), Edoardo Melilli (Author), Josep M. Cruzado (Author), Josep M. Grinyó (Author), Helena Colom (Author), Nuria Lloberas (Author)
Format:	Book
Published:	MDPI AG, 2023-11-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Influence of the Circadian Timing System on Tacrolimus Pharmacokinetics and Pharmacodynamics After Kidney Transplantation
by: Pere Fontova, et al.
Published: (2021)

A Robust and Fast/Multiplex Pharmacogenetics Assay to Simultaneously Analyze 17 Clinically Relevant Genetic Polymorphisms in <i>CYP3A4</i>, <i>CYP3A5</i>, <i>CYP1A2</i>, <i>CYP2C9</i>, <i>CYP2C19</i>, <i>CYP2D6</i>, <i>ABCB1,</i> and <i>VKORC1</i> Genes
by: Camille Tron, et al.
Published: (2022)

Variants in <i>COMT</i>, <i>CYP3A5</i>, <i>CYP2B6,</i> and <i>ABCG2</i> Alter Quetiapine Pharmacokinetics
by: Pablo Zubiaur, et al.
Published: (2021)

The Effect of Intracellular Tacrolimus Exposure on Calcineurin Inhibition in Immediate- and Extended-Release Tacrolimus Formulations
by: Pere Fontova, et al.
Published: (2023)

An Investigational Study on the Role of <i>CYP2D6</i>, <i>CYP3A4</i> and <i>UGT</i>s Genetic Variation on Fesoterodine Pharmacokinetics in Young Healthy Volunteers
by: Andrea Rodríguez-Lopez, et al.
Published: (2024)

Effect of Antibiotic Susceptibility and <i>CYP3A4/5</i> and <i>CYP2C19</i> Genotype on the Outcome of Vonoprazan-Containing <i>Helicobacter pylori</i> Eradication Therapy
by: Mitsushige Sugimoto, et al.
Published: (2020)

<i>CYP3A5*3</i> and <i>SLCO1B1</i> c.521T>C Polymorphisms Influence the Pharmacokinetics of Atorvastatin and 2-Hydroxy Atorvastatin
by: Jin-Woo Park, et al.
Published: (2022)

Afro-Latin American Pharmacogenetics of <i>CYP2D6</i>, <i>CYP2C9</i>, and <i>CYP2C19</i> in Dominicans: A Study from the RIBEF-CEIBA Consortium
by: Mariela Guevara, et al.
Published: (2024)

Guiding the starting dose of the once-daily formulation of tacrolimus in "de novo" adult renal transplant patients: a population approach
by: Beatriz Fernández-Alarcón, et al.
Published: (2024)

<it>CYP3A4 </it>and <it>CYP3A5 </it>genotyping by Pyrosequencing
by: McLeod Howard L, et al.
Published: (2005)

Simple and Robust Detection of <i>CYP2D6</i> Gene Deletions and Duplications Using <i>CYP2D8P</i> as Reference
by: Jens Borggaard Larsen, et al.
Published: (2022)

Brassinosteroid Biosynthetic Gene <i>SlCYP90B3</i> Alleviates Chilling Injury of Tomato (<i>Solanum lycopersicum</i>) Fruits during Cold Storage
by: Songshen Hu, et al.
Published: (2022)

Evaluation of the Influence of <i>CYP2C9* 2, CYP2C9*3</i> Gene Polymorphisms on the Efficacy and Safety of Postoperative Analgesia with Ketoprofen in Patients after Cardiac Surgery
by: T. E. Morozova, et al.
Published: (2021)

CYP3A and CYP2C19 activity in urine in relation to CYP3A4, CYP3A5, and CYP2C19 polymorphisms in Russian peptic ulcer patients taking omeprazole
by: Denisenko NP, et al.
Published: (2018)

Association of polymorphic variants of <i>CYP2C19</i>, <i>P2RY12</i>, <i>ITGB3</i>, <i>ITGA2</i> and <i>eNOS3</i> genes with high residual platelet reactivity while taking clopidogrel and acetylsalicylic acid at different terms of myocardial infarction
by: T. P. Pronko, et al.
Published: (2023)

Predictiveness of the Human-CYP3A4-Transgenic Mouse Model (Cyp3aXAV) for Human Drug Exposure of CYP3A4-Metabolized Drugs
by: David Damoiseaux, et al.
Published: (2022)

Association of CYP3A4*1B, CYP3A4*22 and CYP3A5*3 polymorphisms carriage with efficacy and safety of tamsulosin in patients with benign prostatic hyperplasia
by: Sh. P. Abdullaev, et al.
Published: (2024)

The effect of rs776746 polymorphism in the <i>CYP3A5</i> gene on heart rate when using bisoprolol in patients with acute coronary syndrome
by: V. A. Shumkov, et al.
Published: (2022)

Effects of <i>CYP3A5</i> Genotype on Tacrolimus Pharmacokinetics and Graft-versus-Host Disease Incidence in Allogeneic Hematopoietic Stem Cell Transplantation
by: Daniel N. Marco, et al.
Published: (2024)

Genetic association in CYP3A4 and CYP3A5 genes elevate the risk of prostate cancer
by: Sm Faysal Bellah, et al.
Published: (2023)

Relevance of <i>CYP2D6</i> Gene Variants in Population Genetic Differentiation
by: Anita Stojanović Marković, et al.
Published: (2022)

Pharmacokinetics of asciminib in the presence of CYP3A or P‐gp inhibitors, CYP3A inducers, and acid‐reducing agents
by: Matthias Hoch, et al.
Published: (2022)

Regulatory variants in a novel distal enhancer regulate the expression of CYP3A4 and CYP3A5
by: Joseph M. Collins, et al.
Published: (2022)

Induction of CYP3A by morroniside in rats
by: Shan Xiong, et al.
Published: (2015)

Review on the Synthesis and Therapeutic Potential of Pyrido[2,3-<i>d</i>], [3,2-<i>d</i>], [3,4-<i>d</i>] and [4,3-<i>d</i>]pyrimidine Derivatives
by: Joana F. Campos, et al.
Published: (2022)

Enzymatic Production of 3-OH Phlorizin, a Possible Bioactive Polyphenol from Apples, by <i>Bacillus megaterium</i> CYP102A1 via Regioselective Hydroxylation
by: Ngoc Anh Nguyen, et al.
Published: (2021)

Genetic Variation in <i>CYP2D6</i> and <i>SLC22A1</i> Affects Amlodipine Pharmacokinetics and Safety
by: Paula Soria-Chacartegui, et al.
Published: (2023)

Investigation of the Impact of <i>CYP3A5</i> Polymorphism on Drug-Drug Interaction between Tacrolimus and Schisantherin A/Schisandrin A Based on Physiologically-Based Pharmacokinetic Modeling
by: Qingfeng He, et al.
Published: (2021)

Identification of Selective CYP3A7 and CYP3A4 Substrates and Inhibitors Using a High-Throughput Screening Platform
by: Md Kabir, et al.
Published: (2022)

Expression of CYP3A4 mRNA Is Correlated With CYP3A4 Protein Level and Metabolic Activity in Human Liver
by: Minoru Watanabe, et al.
Published: (2004)

Influence of Genetic Polymorphisms in CYP3A5, CYP3A4, and MDR1 on Tacrolimus Metabolism after kidney transplantation
by: Mirgul Bayanova, et al.
Published: (2024)

<i>CYP2C19</i> Genetic Variants and Major Depressive Disorder: A Systematic Review
by: Larissa Sousa Silva Bonasser, et al.
Published: (2024)

Phenotype of Idiopathic Infantile Hypercalcemia Associated with the Heterozygous Pathogenic Variant of <i>SLC34A1</i> and <i>CYP24A1</i>
by: Teofana Otilia Bizerea-Moga, et al.
Published: (2023)

Ionic Liquid 1-Octyl-3-Methylimidazolium (M8OI) Is Mono-Oxygenated by CYP3A4 and CYP3A5 in Adult Human Liver
by: Alistair C. Leitch, et al.
Published: (2024)

Effect of CYP3 A4, CYP3 A5 and ABCB1 gene polymorphisms on the clinical efficacy of tacrolimus in the treatment of nephrotic syndrome
by: Min Li, et al.
Published: (2018)

Formation of CYP3A‐specific metabolites of ibrutinib in vitro is correlated with hepatic CYP3A activity and 4β‐hydroxycholesterol/cholesterol ratio
by: Jonghwa Lee, et al.
Published: (2023)

The Dynamic Effect of Non-CYP3A4-Metabolized and CYP3A4-Metabolized Statins on Clopidogrel Resistance in Patients With Cerebral Infarction
by: Hong Ting Shi, et al.
Published: (2021)

Ameliorative Effects of <i>Aspergillus awamori</i> against the Initiation of Hepatocarcinogenesis Induced by Diethylnitrosamine in a Rat Model: Regulation of <i>Cyp19</i> and <i>p53</i> Gene Expression
by: Doaa H. Assar, et al.
Published: (2021)

<i>CYP19A1 TC/CC</i> Polymorphism, along with Deletion of <i>GSTM1</i> and <i>GSTT1</i> Genes, Strongly Influences Female Infertility Risk
by: Maria Manuel Casteleiro Alves, et al.
Published: (2023)

Influence of FMO3 and CYP3A4 Polymorphisms on the Pharmacokinetics of Teneligliptin in Humans
by: Jin-Woo Park, et al.
Published: (2021)